English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the zaia usage as premium feature

ZAIA

Presents the pdf analysis as premium feature

PDF Analysis

Insights

Presents the summarisation as premium feature

Summarisation

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the access of premium content as premium feature

Premium Content

Zendy Tools

Zendy Open

bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor a inhibitor infliximab. Arthritis Rheum 2006; 54: 3782-3789. 10. Emi Aikawa N, de Carvalho JF, Artur Almeida Silva C, Bonfá E. Immunogenicity of anti-TNF-alpha agents in autoimmune diseases. Clin Rev Allergy Immunol 2010; 38: 82-89. 11. Weinblatt ME, Keystone EC, Fürst DE, Moreland LW, Weisman MH, Birbara CA, et al. Adalimumab, a fully human anti-ttmior necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum 2003; 48: 35-45. 12. Bender NK, Heilig CE, Droll B, Wohlgemuth J, Armbruster FP, Heilig B. Immunogenieity, efficacy and adverse events of adalimumab in RA patients. Rheumatol Int 2007; 27: 269-274. 13. Bendtzen K. Immunogenicity of anti-TNF antibodies. In: van de Weert M, Möller EH, editors. Immunogenicity of biopharmaceuticals, vol. VIII. Heidelberg: Springer, 2008: 189-203. 14. Bendtzen K, Ainsworth M, Steenholdt C, Thomsen O0, Brynskov J. Individual medicine in inflammatory bowel disease: monitoring bioavailability, pharmacokineties and immunogenicity of anti-tumour necrosis factor-alpha antibodies. Scand J Gastroenterol 2009; 44: 774-781.

Monitoring Peripheral Blood CD4+ Intracellular Adenosine Triphosphate Concentration in Patients with Psoriasis Treated with Fumaric Acid Esters